Breast Lesion Localization Methods Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
The breast lesion localization methods market is forecasted to grow at a CAGR of 11.2% in the foreseeable future. Initially, the COVID-19 pandemic caused a significant downturn in healthcare settings and breast cancer screening programs worldwide, leading to a sharp decline in diagnostic procedures. However, the market is poised for recovery with the relaxation of pandemic restrictions, increased governmental awareness programs, and the reopening of healthcare facilities.
Driving factors include the escalating global prevalence of breast cancer and advancements in localization techniques crucial for identifying and treating breast conditions. Anticipated projections from the GLOBOCAN 2020 report indicate a substantial rise in breast cancer cases, expected to reach over three million new cases by 2040, necessitating increased demand for breast lesion localization procedures.
Government-led initiatives, like the Breast Cancer Affects Us All campaign launched by Wefra Life and Pink Ribbon Germany, aim to boost early detection and prevention through apps like Breast Care, offering comprehensive information in multiple languages.
Additionally, technological strides in breast lesion localization methods have resulted in the development of more sophisticated devices, exemplified by MOLLI Surgical's wire-free localization technology, FDA-approved in May 2021, enhancing accuracy and efficiency during breast cancer surgery.
Despite these promising aspects, stringent regulatory frameworks and the high costs associated with these methods pose potential barriers to market growth in the forecast period.
A pivotal trend is the expected dominance of the wire localization segment, forecasted to witness significant growth due to its precision, cost-effectiveness, and efficacy compared to other techniques. This method, utilizing fine wire to precisely pinpoint abnormal breast tissue, is commonly employed for non-palpable lesions. Research highlights its effectiveness, with reported clean margins between 70.8% and 87.4%, underscoring its significance in breast cancer diagnostics and treatment.
With the rising burden of breast cancer, especially among older demographics, the demand for early detection and effective treatment drives the widespread adoption of wire localization methods in diagnostic and treatment protocols. Consequently, the wire localization segment is poised for substantial growth, driven by its advantages and extensive utilization in breast cancer management.
Comments
Post a Comment